Clinical Trial Update: Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers [Phase 1]

View source ↗

Summary

Phase 1 trial updating on AZD1775 in combination with radiotherapy and chemotherapy for cervical, upper vaginal, and uterine cancers; study status terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Carcinoma
• Endometrioid Adenocarcinoma
• Malignant Female Reproductive System Neoplasm
• Uterine Corpus Cancer
• Vaginal Cancer

Drugs mentioned

• AZD1775 (Adavosertib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Carcinoma, Endometrioid Adenocarcinoma | Phase 1 | Status: TERMINATED | Results posted: 2023-06-06